The Digestive Diseases Research Core Center brings together a multidisciplinary group of independently funded principal investigators and professional supporting personnel from the Departments of Medicine, Pathology, Diagnostic Radiology, Laboratory Medicine, Physiology, Human Genetics and Cell Biology at Yale School of Medicine, in order to further the study of liver structure, function and disease at this institution. The Center focuses on 5 major themes: (1) Mechanisms of hepatic transport and bile secretion; (2) Hepatic metabolic functions including bilirubin metabolism, effects of ethanol, and genetic aspects of mitochondrial enzyme function; (3) Hepatic fibrogenesis; (4) Splanchnic hemodynamics; and (5) Human liver transplantation. The research activities of the Center are broad, and range from fundamental studies of the biology of the hepatocyte to the immediate relevancy of the evaluation of the human liver transplant. The principle goals of the Center have been to: (1) stimulate multidisciplinary interactions; (2) efficiently organize time consuming or costly techniques and procedures in Core Facilities for multiple use; (3) stimulate basic scientists to become involved in one or more of the Center's areas of research interest; (4) capitalize on important new research opportunities through pilot feasibility projects; and (5) create an institutional environment that will greatly amplify progress in answering problems in this important area of Digestive Disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034989-05
Application #
3102082
Study Section
(SRC)
Project Start
1984-09-30
Project End
1989-08-31
Budget Start
1988-09-01
Budget End
1989-08-31
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Yale University
Department
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Garcia-Tsao, Guadalupe (2018) Regression of HCV cirrhosis: Time will tell. Hepatology 67:1651-1653
Hung, Adelina; Garcia-Tsao, Guadalupe (2018) Acute kidney injury, but not sepsis, is associated with higher procedure-related bleeding in patients with decompensated cirrhosis. Liver Int 38:1437-1441
Kaffe, Eleanna; Fiorotto, Romina; Pellegrino, Francesca et al. (2018) ?-Catenin and interleukin-1?-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 67:1903-1919
Goldberg, David S; Levy, Cynthia; Yimam, Kidist et al. (2018) Primary Sclerosing Cholangitis Is Not Rare Among Blacks in a Multicenter North American Consortium. Clin Gastroenterol Hepatol 16:591-593
Cadamuro, Massimiliano; Stecca, Tommaso; Brivio, Simone et al. (2018) The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochim Biophys Acta Mol Basis Dis 1864:1435-1443
Besse, Whitney; Choi, Jungmin; Ahram, Dina et al. (2018) A noncoding variant in GANAB explains isolated polycystic liver disease (PCLD) in a large family. Hum Mutat 39:378-382
Strazzabosco, Mario; Fiorotto, Romina; Cadamuro, Massimiliano et al. (2018) Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium. Biochim Biophys Acta Mol Basis Dis 1864:1374-1379
Murugesan, Vagishwari; Liu, Jun; Yang, Ruhua et al. (2018) Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease. Blood Cells Mol Dis 68:47-53
Sachar, Hamita; Pichetshote, Nipaporn; Nandigam, Kavitha et al. (2018) Continued midazolam versus diphenhydramine in difficult-to-sedate patients: a randomized double-blind trial. Gastrointest Endosc 87:1297-1303
Bhutta, A Q; Garcia-Tsao, G; Reddy, K R et al. (2018) Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation. Aliment Pharmacol Ther 47:78-85

Showing the most recent 10 out of 763 publications